Rab L2A Polyclonal Antibody

Rabbit Anti-Rab L2A Polyclonal Antibody

Product Specifications

Background

RABL2A is a member of the RAB gene family which belongs to the RAS GTPase superfamily. RAB, member of RAS oncogene family-like 2A in the family of RAS-related signaling molecules are small GTP-binding proteins that play important roles in the regulation of exocytotic and endocytotic pathways. RABL2A maps to the site of an ancestral telomere fusion event and may be a subtelomeric gene. Alternative splicing results in multiple transcript variants encoding different isoforms.

CAS Number

9007-83-4

Product Name Alternative

RABL2A; Rab-like protein 2A

Gene ID

11159

Accession Number

Q9UBK7

Reactivity

Human

Immunogen

Synthesized peptide derived from the C-terminal region of human Rab L2A at AA range: 170-250

Clonality

Polyclonal

Tag

Rab-like protein 2A

Applications

WB, IHC, IF, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

30-34kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

Rab L2A Polyclonal Antibody detects endogenous levels of Rab L2A protein.

Observed Molecular Weight

30-34

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000; IHC 1:100-1:300; ELISA 1:20000; IF 1:50-200